ExtremitiesRecon

Report: Smith & Nephew CEO Bohoun to stay put

December 1, 2014 by Brad Perriello

Smith & Nephew (FTSE:SN, NYSE:SNN) CEO Olivier Bohuon reportedly said he has no plans to leave the U.K. medical device maker for the top job at French drug-maker Sanofi (NYSE:SNY), despite persistent reports that he’s the #1 candidate.

Citing “people familiar with the matter,” Bloomberg reported that Bohuon told employees that he’s “very happy” at Smith & Nephew. The CEO spoke at a “town hall” meeting Nov. 25 in Baar, Switzerland, according to 1 of the sources, “who asked not to be identified discussing private company events,” according to Bloomberg.

Bohuon has been mentioned as a strong candidate for the CEO role at Sanofi since early November, when the Paris-based company sacked Chris Viehbacher after 6 years in the corner office. Le Figaroreported Nov. 24 that a deal between Bohuon and Sanofi chairman Serge Weinberg is in the offing.

READ THE REST AT MASSDEVICE

Print Friendly, PDF & Email
Tags

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button
Close